等待开盘 08-20 09:30:00 美东时间
-0.125
-1.59%
今日重点评级关注:RBC Capital:维持Edgewise Therapeutics"跑赢大市"评级,目标价从48美元升至49美元;RBC Capital:维持Nuvation Bio"跑赢大市"评级,目标价从6美元升至7美元
08-11 09:43
N-Able shares are trading higher after the company reported better-than-expecte...
08-07 21:12
N-able (NYSE:NABL) sees Q3 sales of $127.000 million-$128.000 million vs $125.138 million analyst estimate.
08-07 19:03
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
Looking into the current session, N-able Inc. (NYSE:NABL) shares are trading at...
07-17 05:00
N-able (NYSE:NABL) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $0.07 by 14.29 percent. This is a 27.27 percent decrease over earnings of $0.11 per share from the same
05-08 22:04
Financial Outlook for the Second Quarter of 2025N-able management currently expects to achieve the following results for the second quarter of 2025:Total revenue in the range of $125.5 to $126.5 million, representing
05-08 19:14
Companies Reporting Before The Bell • Sempra (NYSE:SRE) is likely to report qua...
05-08 16:33
Needham analyst Mike Cikos reiterates N-able (NYSE:NABL) with a Buy and maintains $10 price target.
05-05 18:34
Platform embeds proactive security measures to protect multiple assets in the Microsoft Cloud, helping businesses defend against evolving threats
04-08 13:49